Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Abeona Therapeutics Inc. (ABEO) had Free Cash Flow per Share of $-0.37 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$8.72M |
|
$-17.07M |
|
$2.70M |
|
$6.02M |
|
$31.75M |
|
$-23.03M |
|
$5.96M |
|
$-17.07M |
|
$-17.07M |
|
$-17.07M |
|
$-17.07M |
|
$-17.07M |
|
$-17.07M |
|
$-23.03M |
|
$-22.16M |
|
56.62M |
|
56.62M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$182.99M |
|
$10.56M |
|
$15.51M |
|
$198.49M |
|
$31.05M |
|
$4.75M |
|
$22.51M |
|
$53.55M |
|
$144.94M |
|
$144.94M |
|
$144.94M |
|
56.87M |
|
| Cash Flow Statement Financials | |
$-19.80M |
|
$4.96M |
|
$-2.22M |
|
$78.44M |
|
$61.37M |
|
$-17.06M |
|
$-2.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.89 |
|
-- |
|
-- |
|
0.03 |
|
0.12 |
|
69.08% |
|
-264.14% |
|
-264.14% |
|
-- |
|
-195.79% |
|
-195.81% |
|
$-20.74M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.45 |
|
1.30 |
|
69.24 |
|
-11.78% |
|
-11.78% |
|
-8.60% |
|
-11.41% |
|
$2.55 |
|
|
Free Cash Flow per Share |
$-0.37 |
$-0.35 |
|